Versacloz Suspension
Product Images NDC 52817-601

20 FDA label images from Trupharma Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Versacloz (NDC 52817-601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Clozapine showing its molecular formula (C18H19ClN4) and molecular weight (326.83). The structure includes a tricyclic ring system with a chlorine atom attached to one ring and a methylated piperazine ring.*
FDA Label Image

Figure-02 Cumulative (Figure 02 Cumulative)

Figure-02 Cumulative (Figure 02 Cumulative)
A line graph depicting cumulative probability over time in months for two drugs: Clozapine and Olanzapine. The x-axis represents time from 0 to 24 months, and the y-axis represents cumulative probability from 0 to 0.5. Clozapine shows a reaching cumulative probability of 24%, while Olanzapine reaches 32% by 24 months, with Clozapine represented by a solid line and Olanzapine by a dashed line.*
FDA Label Image

Patient-use-instruction (Patient Use Instruction)

Patient-use-instruction (Patient Use Instruction)
Illustration showing VERSACLOZ oral suspension bottle and cap, accompanied by two oral syringes labeled as one 1 mL and one 9 mL, and a bottle neck adaptor. The image includes instructions intended for patient use from a pharmacist.*
FDA Label Image

Figure-a-step-1 (Figure A Step 1)

Figure-a-step-1 (Figure A Step 1)
Instructional illustration for VERSACLOZ suspension showing Step 1 to ensure the bottle cap is tightened by turning clockwise and to shake the bottle up and down for 10 seconds before use, accompanied by a figure demonstrating how to shake the bottle well.*
FDA Label Image

Figure-b-step-2 (Figure B Step 2)

Figure-b-step-2 (Figure B Step 2)
An instructional illustration labeled Figure B showing a hand removing a child-resistant cap from a bottle by pushing down then turning counterclockwise. The text instructs to remove the bottle cap by pushing down on it and turning counterclockwise, referencing Figure B as a visual guide.*
FDA Label Image

Figure-c-step-3 (Figure C Step 3)

Figure-c-step-3 (Figure C Step 3)
An instructional diagram labeled Figure C showing how to insert an adaptor into a bottle. The image includes hands pushing the adaptor into the bottle top with an arrow indicating downward movement. Text explains that when first opening a new bottle, push the adaptor into the bottle until the adaptor top aligns with the bottle top.*
FDA Label Image

Step-4 (Step 4)

Step-4 (Step 4)
A text panel titled "Step 4" providing instructions for selecting the correct oral syringe to measure VERSACLOZ (Clozapine) suspension. It advises using a 1 mL syringe for doses 1 mL (50 mg) or less and a larger 9 mL syringe for doses greater than 1 mL (50 mg), referencing Figure D for illustration.*
FDA Label Image

Figure-d (Figure D)

Figure-d (Figure D)
Illustration labeled Figure D showing two oral syringes with detailed volume markings for precise dosing. Close-up views highlight graduations on one syringe ranging from 0.25 mL to 0.75 mL and on the other from 5 mL to 8 mL, assisting accurate measurement of liquid medication doses.*
FDA Label Image

Figure-e-step-5 (Figure E Step 5)

Figure-e-step-5 (Figure E Step 5)
An instructional illustration labeled Figure E showing a hand holding an oral syringe with the plunger being pulled back. Accompanying text instructs to fill the oral syringe with air by drawing back the plunger as part of Step 5 in a procedure.*
FDA Label Image

Figure-f-step-6 (Figure F Step 6)

Figure-f-step-6 (Figure F Step 6)
Illustration showing Step 6 in the administration process for oral suspension medication. It depicts a hand inserting the open tip of an oral syringe into a bottle neck adaptor and pressing down on the syringe plunger to push air from the syringe into the bottle. The diagram is labeled Figure F and accompanied by instructional text.*
FDA Label Image

Figure-g-step-7 (Figure G Step 7)

Figure-g-step-7 (Figure G Step 7)
An instructional diagram labeled Figure G demonstrating Step 7 for using an oral syringe with a medication bottle. The image shows hands holding the bottle upside down with the oral syringe inserted and an arrow indicating to pull back the syringe plunger to draw medicine, cautioning not to pull the plunger completely out. Accompanying text gives detailed instructions for this step.*
FDA Label Image

Figure-h-step-8 (Figure H Step 8)

Figure-h-step-8 (Figure H Step 8)
An instructional diagram labeled Figure H, illustrating Step 8 of a process using an oral syringe to measure liquid medication. The image shows a hand holding a bottle inverted above the syringe with the plunger labeled, indicating how to push the plunger to return medicine and air into the bottle.*
FDA Label Image

Figure-i-step-9 (Figure I Step 9)

Figure-i-step-9 (Figure I Step 9)
Instructional diagram showing how to use an oral syringe to draw medication. It depicts a hand pulling back the syringe plunger downward to draw the correct dose of medicine, labeled as Step 9 and Figure I.*
FDA Label Image

Figure-j-step-10 (Figure J Step 10)

Figure-j-step-10 (Figure J Step 10)
An instructional diagram labeled Figure J shows a hand holding an oral syringe attached to a bottle with a neck adaptor. An arrow indicates lifting the syringe upwards by the plunger while the other hand supports the bottle. Accompanying text gives step 10 instructions for removing the oral syringe from the bottle by turning it upwards and removing it without pushing on the plunger, with a note warning to use the medicine immediately and not store it in the syringe.*
FDA Label Image

Figure-k-step-11 (Figure K Step 11)

Figure-k-step-11 (Figure K Step 11)
An instructional diagram labeled Figure K showing a person administering oral medication with a syringe, demonstrating how to place the syringe tip inside the mouth and push the plunger slowly to swallow the medicine. Accompanying text provides step-by-step guidance for this process.*
FDA Label Image

Figure-l-step-12 (Figure L Step 12)

Figure-l-step-12 (Figure L Step 12)
An instructional illustration labeled 'Figure L' showing hands placing a cap on a bottle and turning it clockwise. Accompanying text instructs to leave the bottle neck adaptor in the bottle, replace the cap, and tighten it by turning clockwise as shown in the figure.*
FDA Label Image

Figure-m-step-13 (Figure M Step 13)

Figure-m-step-13 (Figure M Step 13)
Step 13 in an instructional diagram showing rinsing an oral syringe with warm tap water after use. The illustration depicts a hand holding a syringe under a running faucet and placing the tip in a cup of water to draw water into the syringe. Accompanying text instructs to rinse after each use by filling a cup with water and pulling back the plunger to draw water into the syringe.*
FDA Label Image

Figure-n-step-14 (Figure N Step 14)

Figure-n-step-14 (Figure N Step 14)
An instructional diagram labeled 'Figure N' showing a hand pushing the plunger of an oral syringe to squirt water into a sink. The adjacent text describes Step 14, instructing to push the plunger to expel water and rinse the syringe until clean, then let it air dry and discard any leftover rinse water.*
FDA Label Image

Container Label (312371 Label Versacloz Oral Ssp 50 mg mL 100 mL Us Rev 06.2025)

Container Label (312371 Label Versacloz Oral Ssp 50 mg mL 100 mL Us   Rev 06.2025)
Label for VERSACLOZ (clozapine) Oral Suspension 50 mg/mL by TruPharma LLC. The label includes storage instructions, dosage strength, and a barcode. It specifies oral administration, cautions on storage temperature, and advises dispensing the medication guide with each prescription. The label also shows lot and expiration date placeholders.*
FDA Label Image

Carton Label (312370 Ctn Versacloz Oral Ssp 50 mg mL 100 mL Us Rev 06.2025)

Carton Label (312370 Ctn Versacloz Oral Ssp 50 mg mL 100 mL Us   Rev 06.2025)
Versacloz (clozapine) 50 mg/mL oral suspension carton label distributed by TruPharma LLC. The label indicates the product is for oral administration only, prescription use (Rx Only), and includes instructions to shake well before use. The carton contains one bottle of the suspension, a 1 mL oral syringe, a 9 mL oral syringe, and one bottle adaptor. Storage conditions advise room temperature between 20°C to 25°C with permitted excursions and protection from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.